Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Engineers have developed 3D-printable miniature "fish" that may be capable of propelling themselves through blood vessels and delivering drugs to specific cells.
In a recent study comparing the healing properties of the current standard of care, EpiFix, and Apligraf on persistent diabetic foot wounds, EpiFix, a dehydrated human amnion/chorion membrane…
If your inner trekkie (or trekker) yearns for Star Trek technology in the present day, Scanadu might be paving the way for healthcare's first "tricorder"-like device.
David Ahn, MD, endocrinologist and founder of Sugar Streak, breaks down how and why smart devices are transforming healthcare. Given the boring and rather burdensome nature of recording…
In one of the first clinical trials intended to compare the standard of care for diabetic foot wounds against EpiFix, a dehydrated human amnion/chorion membrane allograft (dHACM), researchers…
